Randy Sweis, MD

Randy Sweis, MD is a physician-scientist who specializes in the treatment of patients using leading-edge immunotherapies and novel investigational approaches. Dr. Sweis has clinical expertise in phase I trials for advanced solid tumors with a focus on genitourinary malignancies. He has served as a Principal Investigator on over 40 clinical trials, including TCR based therapies, intratumoral immunotherapies, checkpoint therapy, cytokine therapy, microbiome-modifying approaches, and viral-, vaccine-, and RNA-based therapies. His laboratory research employs preclinical modeling of solid tumors and computational methods to identify and circumvent mechanisms of resistance to cancer immunotherapies and enhance the immune response against cancer.
Financial relationships
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:AveoTopic:ConsultingDate added:02/09/2025Date updated:02/09/2025Relationship end date:03/01/2024